vs
Acadia Healthcare Company, Inc.（ACHC）与FIVE BELOW, INC（FIVE）财务数据对比。点击上方公司名可切换其他公司
FIVE BELOW, INC的季度营收约是Acadia Healthcare Company, Inc.的1.3倍（$1.0B vs $829.0M），FIVE BELOW, INC净利率更高（3.5% vs 0.5%，领先3.0%），FIVE BELOW, INC同比增速更快（23.1% vs 7.5%），过去两年Acadia Healthcare Company, Inc.的营收复合增速更高（2.0% vs -11.9%）
阿卡迪亚医疗公司是美国的营利性行为医疗健康服务提供商，目前在美国及波多黎各地区运营着超过225家医疗机构，搭建了覆盖广泛的行为健康服务网络，为有相关需求的人群提供专业的心理健康与行为干预服务。
Five Below是美国特色折扣礼品连锁品牌，2002年成立，总部位于宾夕法尼亚州费城，主要面向青少年消费群体，旗下绝大多数商品定价不超过5美元，另有少量精选商品最高定价40美元，目前在全美拥有超过1850家线下门店。
ACHC vs FIVE — 直观对比
营收规模更大
FIVE
是对方的1.3倍
$829.0M
营收增速更快
FIVE
高出15.5%
7.5%
净利率更高
FIVE
高出3.0%
0.5%
两年增速更快
ACHC
近两年复合增速
-11.9%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $829.0M | $1.0B |
| 净利润 | $4.5M | $36.5M |
| 毛利率 | — | 33.8% |
| 营业利润率 | — | 4.2% |
| 净利率 | 0.5% | 3.5% |
| 营收同比 | 7.5% | 23.1% |
| 净利润同比 | -50.8% | 2063.9% |
| 每股收益（稀释后） | $0.05 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACHCFIVE
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $1.0B | ||
| Q3 25 | $851.6M | $1.0B | ||
| Q2 25 | $869.2M | $970.5M | ||
| Q1 25 | $770.5M | $1.4B | ||
| Q4 24 | $774.2M | $843.7M | ||
| Q3 24 | $815.6M | $830.1M | ||
| Q2 24 | $796.0M | $811.9M |
净利润ACHCFIVE
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $36.5M | ||
| Q3 25 | $36.2M | $42.8M | ||
| Q2 25 | $30.1M | $41.1M | ||
| Q1 25 | $8.4M | $187.5M | ||
| Q4 24 | $32.6M | $1.7M | ||
| Q3 24 | $68.1M | $33.0M | ||
| Q2 24 | $78.5M | $31.5M |
毛利率ACHCFIVE
| Q1 26 | — | — | ||
| Q4 25 | — | 33.8% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 40.2% | ||
| Q4 24 | — | 30.6% | ||
| Q3 24 | — | 32.7% | ||
| Q2 24 | — | 32.5% |
营业利润率ACHCFIVE
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 4.2% | ||
| Q3 25 | 4.7% | 5.1% | ||
| Q2 25 | 5.8% | 5.2% | ||
| Q1 25 | 1.7% | 17.7% | ||
| Q4 24 | 4.9% | -0.1% | ||
| Q3 24 | 12.1% | 5.0% | ||
| Q2 24 | 13.4% | 4.5% |
净利率ACHCFIVE
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 3.5% | ||
| Q3 25 | 4.3% | 4.2% | ||
| Q2 25 | 3.5% | 4.2% | ||
| Q1 25 | 1.1% | 13.5% | ||
| Q4 24 | 4.2% | 0.2% | ||
| Q3 24 | 8.4% | 4.0% | ||
| Q2 24 | 9.9% | 3.9% |
每股收益（稀释后）ACHCFIVE
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.66 | ||
| Q3 25 | $0.40 | $0.77 | ||
| Q2 25 | $0.33 | $0.75 | ||
| Q1 25 | $0.09 | $3.40 | ||
| Q4 24 | $0.36 | $0.03 | ||
| Q3 24 | $0.74 | $0.60 | ||
| Q2 24 | $0.85 | $0.57 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $158.5M | $524.5M |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $2.0B | $2.0B |
| 总资产 | $5.5B | $4.8B |
| 负债/权益比越低杠杆越低 | 1.29× | — |
8季度趋势，按日历期对齐
现金及短期投资ACHCFIVE
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | $524.5M | ||
| Q3 25 | $118.7M | $670.2M | ||
| Q2 25 | $131.4M | $624.0M | ||
| Q1 25 | $91.2M | $528.8M | ||
| Q4 24 | $76.3M | $216.6M | ||
| Q3 24 | $82.1M | $327.7M | ||
| Q2 24 | $77.2M | $369.6M |
总债务ACHCFIVE
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
股东权益ACHCFIVE
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.0B | ||
| Q3 25 | $3.1B | $1.9B | ||
| Q2 25 | $3.1B | $1.9B | ||
| Q1 25 | $3.0B | $1.8B | ||
| Q4 24 | $3.1B | $1.6B | ||
| Q3 24 | $3.0B | $1.6B | ||
| Q2 24 | $3.0B | $1.6B |
总资产ACHCFIVE
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $4.8B | ||
| Q3 25 | $6.4B | $4.6B | ||
| Q2 25 | $6.3B | $4.5B | ||
| Q1 25 | $6.1B | $4.3B | ||
| Q4 24 | $6.0B | $4.2B | ||
| Q3 24 | $5.9B | $4.0B | ||
| Q2 24 | $5.7B | $3.9B |
负债/权益比ACHCFIVE
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.5M | $-80.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-133.2M |
| 自由现金流率自由现金流/营收 | — | -12.8% |
| 资本支出强度资本支出/营收 | — | 5.1% |
| 现金转化率经营现金流/净利润 | 13.78× | -2.19× |
| 过去12个月自由现金流最近4个季度 | — | $323.0M |
8季度趋势，按日历期对齐
经营现金流ACHCFIVE
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $-80.1M | ||
| Q3 25 | $73.2M | $93.0M | ||
| Q2 25 | $133.5M | $132.7M | ||
| Q1 25 | $11.5M | $363.5M | ||
| Q4 24 | $116.7M | $-30.6M | ||
| Q3 24 | $163.1M | $71.3M | ||
| Q2 24 | $171.1M | $26.4M |
自由现金流ACHCFIVE
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $-133.2M | ||
| Q3 25 | $-63.0M | $48.3M | ||
| Q2 25 | $-34.2M | $96.5M | ||
| Q1 25 | $-163.2M | $311.4M | ||
| Q4 24 | $-86.8M | $-111.0M | ||
| Q3 24 | $-27.1M | $-32.4M | ||
| Q2 24 | $16.9M | $-61.4M |
自由现金流率ACHCFIVE
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | -12.8% | ||
| Q3 25 | -7.4% | 4.7% | ||
| Q2 25 | -3.9% | 9.9% | ||
| Q1 25 | -21.2% | 22.4% | ||
| Q4 24 | -11.2% | -13.2% | ||
| Q3 24 | -3.3% | -3.9% | ||
| Q2 24 | 2.1% | -7.6% |
资本支出强度ACHCFIVE
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 5.1% | ||
| Q3 25 | 16.0% | 4.4% | ||
| Q2 25 | 19.3% | 3.7% | ||
| Q1 25 | 22.7% | 3.7% | ||
| Q4 24 | 26.3% | 9.5% | ||
| Q3 24 | 23.3% | 12.5% | ||
| Q2 24 | 19.4% | 10.8% |
现金转化率ACHCFIVE
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | -2.19× | ||
| Q3 25 | 2.02× | 2.17× | ||
| Q2 25 | 4.43× | 3.22× | ||
| Q1 25 | 1.37× | 1.94× | ||
| Q4 24 | 3.58× | -18.13× | ||
| Q3 24 | 2.39× | 2.16× | ||
| Q2 24 | 2.18× | 0.84× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
FIVE
暂无分部数据
